Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis
about
Citrate salts for preventing and treating calcium containing kidney stones in adultsPharmacological interventions for preventing recurrent urinary stones in adults and childrenCitrate salts for preventing and treating kidney stonesPharmacological interventions for preventing recurrent urinary stones in adults and childrenPharmacological interventions for preventing complications in idiopathic hypercalciuriaKidney stone disease.Medical and alternative therapies in urinary tract stone diseaseDiet-induced acidosis: is it real and clinically relevant?Nephrocalcinosis in preterm babiesWhat do we know about pediatric renal microlithiasis?Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size.Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature.Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.Effect of citrus-based products on urine profile: A systematic review and meta-analysis.The role of calcium in the prevention of kidney stones.Effect of potassium magnesium citrate and vitamin B-6 prophylaxis for recurrent and multiple calcium oxalate and phosphate urolithiasis.Update on dietary recommendations and medical treatment of renal stone disease.Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.Association between schizophrenia and urinary calculi: a population-based case-control study.Pharmacotherapy of urolithiasis: evidence from clinical trials.Pharmacology of stone diseaseNephrolithiasis-associated bone disease: pathogenesis and treatment options.Intravenous Vitamin C and Cancer: A Systematic Review.Clinical practice. Calcium kidney stones.ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.Effects of non-pharmacological interventions on urinary citrate levels: a systematic review and meta-analysis.Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.Acidosis: An Old Idea Validated by New Research.Urolithiasis in children: medical approachEvaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy in children with urolithiasisThe CARI guidelines. Kidney stones: prevention of recurrent calcium nephrolithiasis.Medical management of urinary stone disease.Potassium and health.Epidemiology of stone disease.Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population HealthKidney stones: an update on current pharmacological management and future directions.Thiosulfate reduces calcium phosphate nephrolithiasis.Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial.
P2860
Q24186599-762144CE-8477-475A-98D3-8019EC8D58A4Q24194727-6FC7404C-D005-4E43-A0D4-BA410E9FC619Q24201267-7835A54F-14D8-4860-98DC-92057123A274Q24202533-0F7F9E71-04A1-4C76-B723-B8BB559BC16FQ24241657-877A061D-B27A-4068-A757-A8F9906C811AQ24536113-F2E414E8-C022-4FCB-8AC5-86CC15E4A470Q26777616-5C0DE232-6DC2-4692-B339-1203BB497069Q28267307-B3F42FA4-CCDC-40C2-A93F-08E2AB8F42D2Q28362357-7BB254E8-0A1E-44ED-A8BD-EA8F7CB31977Q30234488-88C54D73-74CF-4B13-BA8A-528534D4A74EQ30367714-779F61D8-E44A-4B89-8F0A-79CD37C60095Q31057241-C91535E1-AECE-4ACC-AB62-84844D58D10DQ33532262-2B5A24B8-F1E6-42D9-806D-64867B7F6E6FQ33639660-8BCCB912-C294-4B21-A7B2-C99E129BBF6AQ33672231-AE6DE61D-3557-414A-B9CC-8EEEA7BE7397Q33746699-BD91DD1B-D2DE-4713-82C2-4A1C02CD701BQ33780071-1239A59E-54BE-4E30-A533-049324979403Q33801862-A12C9566-47F9-4377-969A-FBFC19265C21Q34265048-74B6F0C1-46D0-47C7-936F-355473B00B48Q34304464-71FA2239-FD19-42E1-AA97-7A831BF1BA14Q34625474-B885EF62-0303-4DF4-9DD8-5DB643342828Q34936200-A7ED454D-009D-41F5-8A75-D618406A9A93Q34936294-ECC45848-FE32-4888-898A-9103B7C2E16EQ34936324-69875268-156F-4EB2-812D-5178BE64F8BFQ35175163-BFEC6745-78F1-4003-8F95-19F079C7DE01Q35335724-1B8DAC22-AF7D-481E-A5E3-C32ABCA2B28DQ35588351-F8460E6D-D12A-4885-A8B9-A6BFA7BB4D1DQ35756780-08FEA81A-3B81-4EDA-B802-AB1D044B17E4Q36033738-7EE6C4B5-CA3F-4E85-B922-D63E6BA4AD1AQ36050705-5A389578-F0E0-4CA1-8B70-AE78746BA212Q36186402-E9262FD9-5857-42D3-B1DA-BBF4A164EFC7Q36422649-C9047344-6490-46E7-9166-BDA91C33C87BQ36742487-FA476410-582C-46F0-8C01-4EB79774C067Q36828140-82D82780-6ADA-4C1D-BB11-A9A2D8198585Q36832975-39B12A03-A639-4808-8F36-64CBE415FBC7Q36902334-15DA9085-DB33-4597-A52E-64BBE0EC1C7AQ37070036-B9C04411-81BE-4779-A8B2-14B9B9E986D7Q37169623-2E9E829D-E0BE-4EE1-82B8-FA9A9B536405Q37211104-A863FE36-307E-4175-90DF-E9834976C220Q37357212-3E867AE8-A30F-4489-AD9B-BC7A9A28D803
P2860
Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@ast
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@en
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@nl
type
label
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@ast
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@en
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@nl
prefLabel
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@ast
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@en
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@nl
P2093
P3181
P1476
Potassium-magnesium citrate is ...... alcium oxalate nephrolithiasis
@en
P2093
P304
P3181
P356
10.1016/S0022-5347(01)68155-2
P407
P577
1997-12-01T00:00:00Z